Invention Grant
- Patent Title: 3,6-methano-1H-pyrrolo[3,2-b]pyridine and 3,6-methano-1H-pyrrolo[3,2-C]pyridine compounds and medicaments using same
-
Application No.: US16791715Application Date: 2020-02-14
-
Publication No.: US11292794B2Publication Date: 2022-04-05
- Inventor: Hiroyuki Kouji , Kentaro Yamada , Akira Katoh , Toshimasa Ishizaki , Shigeru Matsuoka , Akira Nishizono , Tadashi Mishina , Atsushi Yoshimori
- Applicant: Oita University Institute of Advanced Medicine, Inc.
- Applicant Address: JP Oita
- Assignee: Oita University Institute of Advanced Medicine, Inc.
- Current Assignee: Oita University Institute of Advanced Medicine, Inc.
- Current Assignee Address: JP Oita
- Agency: Seed IP Law Group LLP
- Priority: JPJP2018-153227 20180816
- Main IPC: C07D471/08
- IPC: C07D471/08 ; C07D471/18 ; A61P31/14 ; A61P35/00
![3,6-methano-1H-pyrrolo[3,2-b]pyridine and 3,6-methano-1H-pyrrolo[3,2-C]pyridine compounds and medicaments using same](/abs-image/US/2022/04/05/US11292794B2/abs.jpg.150x150.jpg)
Abstract:
The present disclosure provides a compound that is useful for the treatment and prophylaxis of rabies. The present disclosure provides a compound represented by formula XXIF or formula XXIB: wherein R1, R2A, R2B, R3, and R4 are defined in the specification, a solvent, or a pharmaceutically acceptable salt thereof, use of such a compound, solvate, or pharmaceutically acceptable salt thereof for the treatment or prophylaxis of rabies and cancer, a pharmaceutical composition comprising such a compound, solvate, or pharmaceutically acceptable salt thereof, and a method for the treatment or prophylaxis of rabies and cancer using the same.
Public/Granted literature
- US20210214356A1 COMPOUNDS AND MEDICAMENTS USING SAME Public/Granted day:2021-07-15
Information query